The Discounted Cash Flow (DCF) valuation of Dicerna Pharmaceuticals Inc (DRNA) is (143.72) USD. With the latest stock price at 38.22 USD, the upside of Dicerna Pharmaceuticals Inc based on DCF is -476.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.5% | 6.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (535.46) - (83.71) | (143.72) |
| Upside | -1501.0% - -319.0% | -476.0% |